NEW YORK (GenomeWeb) – T2 Biosystems reported after the close of the market Tuesday that its revenues dropped 14 percent in the first quarter as higher product sales were offset by lower research revenues year over year.

The Lexington, Massachusetts-based molecular diagnostics firm reported total revenues of $941,000, down from $1.1 million in Q1 2016 and well below analysts' average expectation of $2 million.

Its product revenues were $631,000 versus $437,000 in Q1 2016, while its research revenues were $310,000 compared to $659,000 a year ago.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.